Key result
Frailty linked to ~3.5-fold higher mortality in PAH.
Why the study?
Patients with pulmonary arterial hypertension are at high risk of frailty, but frailty has been understudied in this population.
Cohort (n=80)
No
Frailty is highly prevalent in patients with pulmonary arterial hypertension and is independently associated with increased visceral adiposity, worse quality of life, and a more than 3-fold increased risk of mortality.
Answers are grounded in this paper and cite their sources.
May warrant frailty assessment in PAH evaluation; extends general observations but remains hypothesis-generating pending validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Farley et al. (2026) conducted a cohort in Pulmonary Arterial Hypertension (n=80). Frailty or pre-frailty (SPPB score ≤ 9) vs. Non-frail (SPPB score > 9) was evaluated on Mortality (HR 3.55, 95% CI 1.21-10.42). Frailty was present in 49% of patients with pulmonary arterial hypertension and was associated with a increased risk of death.
Synapse has enriched 10 related papers. Consider them for comparative context: